公开(公告)号：EP3204011A4

公开(公告)日：2018-06-20

申请号：EP15849514

申请日：2015-10-07

申请人： SAGE THERAPEUTICS INC

发明人： QUIRK MICHAEL C ,  DOHERTY JAMES J ,  MARTINEZ BOTELLA GABRIEL

IPC分类号： A61K31/56 ,  A61P25/28

CPC分类号： A61K31/575 ,  A61K31/00 ,  A61K45/00 ,  A61K45/06 ,  A61K2300/00

摘要： Methods for treating a subject suffering from a sterol synthesis disorder or a sterol deficiency disorder, e.g., Smith-Lemli-Opitz syndrome, the method comprising administering to the subject an effective amount of an NMDA receptor modulating compound, are provided.